Insight Pharma Reports Release Prenatal Diagnostics Research Report

Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
 
NEEDHAM, Mass. - May 30, 2014 - PRLog -- Insight Pharma Reports releases a new report focusing on Prenatal Diagnostics.  The report, Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor, discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare.

In addition to covering several aspects of prenatal diagnostics, this report also includes specifications of particular instruments, exclusive interviews with CEOs, CSOs, and Vice Presidents of the participating companies, which include Ariosa Diagnostics, Metabolomic Diagnostics, Natera, NX PharmaGen, Sequenom, Silicon Biosystems, and Verinata Health.  Specific areas of focus include company goals, customer feedback, challenges encountered, competitive advantage, platform pricing, and future endeavors. A survey capturing the demographics of the prenatal industry is presented at the end of the report, specifically highlighting organizational background, areas of research, challenges encountered, and applications in development.

For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com/Prenatal-Diagnostic-T... or contact Kerri Kelley at kkelley@healthtech.com or 781-972-1347.

About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/

Contact
Kerri Kelley
***@insightpharmareports.com
781-972-1347
End
Source: » Follow
Email:***@insightpharmareports.com Email Verified
Tags:Prenatal, Prenatal Diagnostics, Health, Biotech, Pharma
Industry:Biotech, Medical
Location:Needham - Massachusetts - United States
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Insight Pharma Reports News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share